 Cytoreductive surgery disseminated non-seminomatous germ cell tumours testis Between patients underwent surgical removal residual metastatic deposits aggressive chemotherapy regimen cisplatin vincristine methotrexate bleomycin etoposide actinomycin cyclophosphamide germ cell tumours testis stage IIB Ninety-one surgical procedures cent retroperitoneal lymph node dissections cent thoracotomies cent hepatic resections cent craniotomies cent orchidectomies anterolateral decompression vertebral column Nine cent patients repeat retroperitoneal node dissection patient repeat thoracotomy recurrent metastatic deposits period follow-up Multivisceral resections vascular reconstruction procedures cent patients retroperitoneal node dissection Fifty-five cent patients complete remission mean follow-up period months months Nine cent patients metastatic disease months years operation deaths perioperative period cent histology resected metastases undifferentiated active tumour cent patients differentiated mature teratoma cent patients fibrosis/necrosis cent patients Twelve cent patients undifferentiated elements patients cent preoperative tumour markers poor prognostic categories complete remission Cytoreductive surgery patients metastatic germ cell chance remission chemotherapy poor prognostic group categories